tropolone has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sumathi, T; Varier, KM | 1 |
| Bagli, J; Bogri, T; Voith, K | 1 |
2 other study(ies) available for tropolone and Parkinson Disease
| Article | Year |
|---|---|
Hinokitiol Offers Neuroprotection Against 6-OHDA-Induced Toxicity in SH-SY5Y Neuroblastoma Cells by Downregulating mRNA Expression of MAO/α-Synuclein/LRRK2/PARK7/PINK1/PTEN Genes.
Topics: alpha-Synuclein; Apoptosis; Cell Line, Tumor; Down-Regulation; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Monoamine Oxidase; Monoterpenes; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Protein Deglycase DJ-1; Protein Kinases; PTEN Phosphohydrolase; RNA, Messenger; Tropolone | 2019 |
Troponoids. 6. Troponylpiperazines: a new class of dopamine agonists.
Topics: Animals; Bromocriptine; Cycloheptanes; Disease Models, Animal; Hydroxydopamines; Male; Oxidopamine; Parkinson Disease; Piperazines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Structure-Activity Relationship; Tropolone | 1984 |